A citation-based method for searching scientific literature

J D Palmer, M E Gamez, K Ranta, H Ruiz-Garcia, J L Peterson, D M Blakaj, D Prevedello, R Carrau, A Mahajan, K L Chaichana, D M Trifiletti. J Neurooncol 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


CpG and Non-CpG Methylation in Epigenetic Gene Regulation and Brain Function.
Hyun Sik Jang, Woo Jung Shin, Jeong Eon Lee, Jeong Tae Do. Genes (Basel) 2017
161
100

Genetics and Epigenetics of Glioblastoma: Applications and Overall Incidence of IDH1 Mutation.
Aizhen Liu, Chunfeng Hou, Hongfang Chen, Xuan Zong, Peijun Zong. Front Oncol 2016
37
100

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases.
Eric J Lehrer, Heather M McGee, Jennifer L Peterson, Laura Vallow, Henry Ruiz-Garcia, Nicholas G Zaorsky, Sonam Sharma, Daniel M Trifiletti. Int J Mol Sci 2018
28
100

Glioblastoma: Overview of Disease and Treatment.
Mary Elizabeth Davis. Clin J Oncol Nurs 2016
444
100

A review of cancer immunotherapy toxicity.
Lucy Boyce Kennedy, April K S Salama. CA Cancer J Clin 2020
294
100

CAR T cells for brain tumors: Lessons learned and road ahead.
David Akhavan, Darya Alizadeh, Dongrui Wang, Michael R Weist, Jennifer K Shepphird, Christine E Brown. Immunol Rev 2019
93
100

Management of glioblastoma after recurrence: A changing paradigm.
Supriya Mallick, Rony Benson, Abdul Hakim, Goura K Rath. J Egypt Natl Canc Inst 2016
40
100

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.
John H Sampson, Kenneth D Aldape, Gary E Archer, April Coan, Annick Desjardins, Allan H Friedman, Henry S Friedman, Mark R Gilbert, James E Herndon, Roger E McLendon,[...]. Neuro Oncol 2011
232
100

Integration of immuno-oncology with stereotactic radiosurgery in the management of brain metastases.
Eric J Lehrer, Heather M McGee, Jason P Sheehan, Daniel M Trifiletti. J Neurooncol 2021
7
100

The evolution of stereotactic radiosurgery in neurosurgical practice.
Daniel M Trifiletti, Henry Ruiz-Garcia, Alfredo Quinones-Hinojosa, Rohan Ramakrishna, Jason P Sheehan. J Neurooncol 2021
2
100

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients.
Eudocia Q Lee, Thomas J Kaley, Dan G Duda, David Schiff, Andrew B Lassman, Eric T Wong, Tom Mikkelsen, Benjamin W Purow, Alona Muzikansky, Marek Ancukiewicz,[...]. Clin Cancer Res 2015
48
100

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.
Johanna Buchroithner, Friedrich Erhart, Josef Pichler, Georg Widhalm, Matthias Preusser, Günther Stockhammer, Martha Nowosielski, Sarah Iglseder, Christian F Freyschlag, Stefan Oberndorfer,[...]. Cancers (Basel) 2018
34
100

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Louis Burt Nabors, Jana Portnow, Manmeet Ahluwalia, Joachim Baehring, Henry Brem, Steven Brem, Nicholas Butowski, Jian L Campian, Stephen W Clark, Andrew J Fabiano,[...]. J Natl Compr Canc Netw 2020
86
100

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
100

Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in Korea.
Doo-Sik Kong, Do-Hyun Nam, Shin-Hyuk Kang, Jae Won Lee, Jong-Hee Chang, Jeong-Hoon Kim, Young-Jin Lim, Young-Cho Koh, Yong-Gu Chung, Jae-Min Kim,[...]. Oncotarget 2017
50
100

Immunotherapy for Glioblastoma: Adoptive T-cell Strategies.
Bryan D Choi, Marcela V Maus, Carl H June, John H Sampson. Clin Cancer Res 2019
44
100

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.
Walter Stummer, Hanns-Jürgen Reulen, Thomas Meinel, Uwe Pichlmeier, Wiebke Schumacher, Jörg-Christian Tonn, Veit Rohde, Falk Oppel, Bernd Turowski, Christian Woiciechowsky,[...]. Neurosurgery 2008
656
100

Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Alvin R Cabrera, John P Kirkpatrick, John B Fiveash, Helen A Shih, Eugene J Koay, Stephen Lutz, Joshua Petit, Samuel T Chao, Paul D Brown, Michael Vogelbaum,[...]. Pract Radiat Oncol 2016
98
100

The Safety of available immunotherapy for the treatment of glioblastoma.
S Harrison Farber, Aladine A Elsamadicy, Ahmet Fatih Atik, Carter M Suryadevara, Pakawat Chongsathidkiet, Peter E Fecci, John H Sampson. Expert Opin Drug Saf 2017
10
100

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
100

The use of convection-enhanced delivery with liposomal toxins in neurooncology.
Massimo S Fiandaca, Mitchel S Berger, Krystof S Bankiewicz. Toxins (Basel) 2011
19
100


Management of glioblastoma: State of the art and future directions.
Aaron C Tan, David M Ashley, Giselle Y López, Michael Malinzak, Henry S Friedman, Mustafa Khasraw. CA Cancer J Clin 2020
320
100

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913.
Prakash Chinnaiyan, Minhee Won, Patrick Y Wen, Amyn M Rojiani, Maria Werner-Wasik, Helen A Shih, Lynn S Ashby, Hsiang-Hsuan Michael Yu, Volker W Stieber, Shawn C Malone,[...]. Neuro Oncol 2018
66
100


Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data.
Eric J Lehrer, Jennifer Peterson, Paul D Brown, Jason P Sheehan, Alfredo Quiñones-Hinojosa, Nicholas G Zaorsky, Daniel M Trifiletti. Radiother Oncol 2019
119
100

Awake vs. asleep motor mapping for glioma resection: a systematic review and meta-analysis.
Paola Suarez-Meade, Lina Marenco-Hillembrand, Calder Prevatt, Ricardo Murguia-Fuentes, Alea Mohamed, Thannon Alsaeed, Eric J Lehrer, Tara Brigham, Henry Ruiz-Garcia, David Sabsevitz,[...]. Acta Neurochir (Wien) 2020
19
100

Advances in Brain Tumor Surgery for Glioblastoma in Adults.
Montserrat Lara-Velazquez, Rawan Al-Kharboosh, Stephanie Jeanneret, Carla Vazquez-Ramos, Deependra Mahato, Daryoush Tavanaiepour, Gazanfar Rahmathulla, Alfredo Quinones-Hinojosa. Brain Sci 2017
117
100



Immunotherapies: Exploiting the Immune System for Cancer Treatment.
Jeffrey Koury, Mariana Lucero, Caleb Cato, Lawrence Chang, Joseph Geiger, Denise Henry, Jennifer Hernandez, Fion Hung, Preet Kaur, Garrett Teskey,[...]. J Immunol Res 2018
44
100

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
100

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.
Hideho Okada, Michael Weller, Raymond Huang, Gaetano Finocchiaro, Mark R Gilbert, Wolfgang Wick, Benjamin M Ellingson, Naoya Hashimoto, Ian F Pollack, Alba A Brandes,[...]. Lancet Oncol 2015
382
100


Experimental therapies: gene therapies and oncolytic viruses.
M Maher Hulou, Choi-Fong Cho, E Antonio Chiocca, Rolf Bjerkvig. Handb Clin Neurol 2016
11
100

Inflammatory Mediators in Glioma Microenvironment Play a Dual Role in Gliomagenesis and Mesenchymal Stem Cell Homing: Implication for Cellular Therapy.
Rawan Al-Kharboosh, Karim ReFaey, Montserrat Lara-Velazquez, Sanjeet S Grewal, Jaime Imitola, Alfredo Quiñones-Hinojosa. Mayo Clin Proc Innov Qual Outcomes 2020
20
100

Current State of Immunotherapy for Treatment of Glioblastoma.
Tresa McGranahan, Kate Elizabeth Therkelsen, Sarah Ahmad, Seema Nagpal. Curr Treat Options Oncol 2019
133
100

Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer: A Systematic Review and Meta-analysis.
Eric J Lehrer, Raj Singh, Ming Wang, Vernon M Chinchilli, Daniel M Trifiletti, Piet Ost, Shankar Siva, Mao-Bin Meng, Leila Tchelebi, Nicholas G Zaorsky. JAMA Oncol 2021
45
100

Treating recurrent glioblastoma: an update.
Carlos Kamiya-Matsuoka, Mark R Gilbert. CNS Oncol 2015
38
100

Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity.
Orneala Bakos, Christine Lawson, Samuel Rouleau, Lee-Hwa Tai. J Immunother Cancer 2018
61
100


Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.
Lee A Wheeler, Andrea G Manzanera, Susan D Bell, Robert Cavaliere, John M McGregor, John C Grecula, Herbert B Newton, Simon S Lo, Behnam Badie, Jana Portnow,[...]. Neuro Oncol 2016
86
100

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
100

Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group.
Michael A Vogelbaum, Sarah Jost, Manish K Aghi, Amy B Heimberger, John H Sampson, Patrick Y Wen, David R Macdonald, Martin J Van den Bent, Susan M Chang. Neurosurgery 2012
158
100

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives.
Bas Weenink, Pim J French, Peter A E Sillevis Smitt, Reno Debets, Marjolein Geurts. Cancers (Basel) 2020
36
100

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.
Roger Stupp, Monika E Hegi, Thierry Gorlia, Sara C Erridge, James Perry, Yong-Kil Hong, Kenneth D Aldape, Benoit Lhermitte, Torsten Pietsch, Danica Grujicic,[...]. Lancet Oncol 2014
591
100

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.
Patrick Y Wen, David A Reardon, Terri S Armstrong, Surasak Phuphanich, Robert D Aiken, Joseph C Landolfi, William T Curry, Jay-Jiguang Zhu, Michael Glantz, David M Peereboom,[...]. Clin Cancer Res 2019
73
100

An overview of cancer immunotherapeutic strategies.
Braira Wahid, Amjad Ali, Shazia Rafique, Muhammad Waqar, Muhammad Wasim, Khansa Wahid, Muhammad Idrees. Immunotherapy 2018
15
100

A guide to cancer immunotherapy: from T cell basic science to clinical practice.
Alex D Waldman, Jill M Fritz, Michael J Lenardo. Nat Rev Immunol 2020
729
100

The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application.
Silvia Minozzi, Michela Cinquini, Silvia Gianola, Marien Gonzalez-Lorenzo, Rita Banzi. J Clin Epidemiol 2020
39
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.